Companies: 10,795·Total market cap: $144.5T
Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.

GLSINASDAQHealthcare● Active
$21.65
$-0.60(-2.70%)
Market Cap$317783203
P/E Ratio
52W High$34.1
52W Low$7.78
Overview

Greenwich LifeSciences, Inc. (GLSI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GLSI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.57glsi eps ttm · glsi earnings per shareEarnings history
PE Ratio (TTM)glsi pe ratio ttm · glsi price to earningsPE Ratio deep dive
Revenue (TTM)3558.00glsi revenue ttm · glsi annual revenueFull revenue history
Dividend YieldNo Dividenddoes glsi pay dividends · glsi dividend yieldDividend history
Shares Outstanding13.5Mglsi shares outstanding · glsi floatShares outstanding history
Next EarningsAug 13, 2026Est.glsi earnings date · glsi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
greenwich lifesciences, inc. revenue · glsi revenue 2025
FY 2025Net Income-$19.4M▼ 22.61% YoY
202320242025
greenwich lifesciences, inc. net income · glsi profit 2025
FY 2025EPS$-1.43▼ 18.18% YoY
202320242025
glsi eps · greenwich lifesciences, inc. earnings per share 2025
TTM:Revenue: $3558.00Net Income: -$21.8MEPS: $-1.57View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis glsi a buy · glsi analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$50.00Low
$21.65Current
$50.00Avg Target130.95% upside
$50.00High
glsi price target · glsi 12 month forecast

Total: 2 · Buy rate: 100.0%

The GLSI analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $50.00, representing +130.95% upside from the current price of $21.65.

Stock Performance

Full History
1D-2.70%
1W-10.91%
1M-5.29%
3M-6.24%
YTD+3.05%
1Y+129.10%
5Y-41.34%

About Greenwich LifeSciences, Inc.

CEOSnehal S. Patel
IPO DateSep 25, 2020
Employees4
CountryUS

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer…

what is greenwich lifesciences, inc. · glsi stock overview · greenwich lifesciences, inc. company profile · who is greenwich lifesciences, inc. ceo · glsi NASDAQ · greenwich lifesciences, inc. headquarters · greenwich lifesciences, inc. business segments

About Stock Overview & Key Data

Greenwich LifeSciences, Inc. (GLSI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 25, 2020. As of the latest trading session, GLSI stock price is $21.65, with a market capitalization of $317.8M. The stock has returned +129.10% over the past 12 months and +3.05% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Greenwich LifeSciences, Inc. stock is Buy, with an average 12-month price target of $50.00. In fiscal year 2025, Greenwich LifeSciences, Inc. reported revenue of — and net income of -$19.4M. For detailed data — including Greenwich LifeSciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Greenwich LifeSciences, Inc. (GLSI) stock price is $21.65. The stock is traded on NASDAQ under the ticker symbol GLSI. The 52-week range is $7.78 – $34.10.

GLSI stock priceGLSI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice